167 related articles for article (PubMed ID: 20926779)
1. Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism.
Suarez J; Scott BT; Suarez-Ramirez JA; Chavira CV; Dillmann WH
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1524-9. PubMed ID: 20926779
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy.
Mutlak M; Schlesinger-Laufer M; Haas T; Shofti R; Ballan N; Lewis YE; Zuler M; Zohar Y; Caspi LH; Kehat I
Int J Cardiol; 2018 Nov; 270():204-213. PubMed ID: 29857938
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
[TBL] [Abstract][Full Text] [Related]
5. [The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic constriction].
Fu DT; Tu J; Cai YQ; Cai ZW; Zhang LZ; Liu JY; Xu SC; Wang DJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):33-38. PubMed ID: 32476371
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
7. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
8. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy.
Kinugawa K; Yonekura K; Ribeiro RC; Eto Y; Aoyagi T; Baxter JD; Camacho SA; Bristow MR; Long CS; Simpson PC
Circ Res; 2001 Sep; 89(7):591-8. PubMed ID: 11577024
[TBL] [Abstract][Full Text] [Related]
9. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hypertrophy and thyroid hormone signaling.
Dillmann W
Heart Fail Rev; 2010 Mar; 15(2):125-32. PubMed ID: 19125327
[TBL] [Abstract][Full Text] [Related]
11. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.
Ruppert C; Deiss K; Herrmann S; Vidal M; Oezkur M; Gorski A; Weidemann F; Lohse MJ; Lorenz K
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7440-5. PubMed ID: 23589880
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone receptor function in maturing ovine cardiomyocytes.
Chattergoon NN; Louey S; Scanlan T; Lindgren I; Giraud GD; Thornburg KL
J Physiol; 2019 Apr; 597(8):2163-2176. PubMed ID: 30770568
[TBL] [Abstract][Full Text] [Related]
13. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
14. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
[TBL] [Abstract][Full Text] [Related]
16. The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy.
Xu W; Hou D; Jiang X; Lu Z; Guo T; Liu Y; Wang D; Zen K; Yu B; Zhang CY
J Cell Physiol; 2012 Sep; 227(9):3243-53. PubMed ID: 22105890
[TBL] [Abstract][Full Text] [Related]
17. Erbin is a negative modulator of cardiac hypertrophy.
Rachmin I; Tshori S; Smith Y; Oppenheim A; Marchetto S; Kay G; Foo RS; Dagan N; Golomb E; Gilon D; Borg JP; Razin E
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5902-7. PubMed ID: 24711380
[TBL] [Abstract][Full Text] [Related]
18. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
19. M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.
Rozanski A; Takano AP; Kato PN; Soares AG; Lellis-Santos C; Campos JC; Ferreira JC; Barreto-Chaves ML; Moriscot AS
Mol Endocrinol; 2013 Dec; 27(12):2055-65. PubMed ID: 24176915
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling?
Pantos C; Xinaris C; Mourouzis I; Malliopoulou V; Kardami E; Cokkinos DV
Mol Cell Biochem; 2007 Mar; 297(1-2):65-72. PubMed ID: 17024559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
